BioSpace News Archive

Medical Carts Market Global Industry Overview and Upcoming Future Opportunities

The evolving healthcare sector has raised its demand for a multitude of equipment.

February 15, 2022

·

6 min read

Business

Lantern Pharma Expands into Additional Pediatric Cancers Through a Collaboration with The Greehey Children’s Cancer Research Institute (GCCRI) at University of Texas Health Science Center-San Antonio

Lantern Pharma today announced that it is expanding opportunities for its portfolio of drug candidates and A.I. drug discovery platform into additional rare pediatric cancers through a collaboration with The Greehey Children’s Cancer Research Institute (GCCRI) at the University of Texas Health Science Center at San Antonio (UTHSCSA).

February 15, 2022

·

10 min read

Business

Salix Announces 2022 Gastrointestinal Health Scholars Program

Bausch Health Companies Inc. today announced the opening of the 2022 Salix Gastrointestinal Health Scholars Program application period.

February 15, 2022

·

4 min read

Biotech Beach

Terray Therapeutics Launches with $60M to Deliver Premium Chemical Data at Unrivaled Scale, Unlocking the Potential of AI-Driven Small Molecule Drug Discovery

Terray Therapeutics today announced the closing of a $60 million Series A financing to advance its novel tNova platform and deliver therapies to patients faster than ever before.

February 15, 2022

·

3 min read

Business

SciNeuro Pharmaceuticals and Alamar Biosciences Collaborate to Discover Novel Therapeutic Antibodies for CNS Diseases

Alamar Biosciences and SciNeuro Pharmaceuticals announced a multi-program collaboration and license agreement to discover and develop novel therapeutic antibodies for targets selected by SciNeuro within the field of neurological diseases, based on Alamar’s Attobody platform.

February 15, 2022

·

3 min read

FDA

Foundation Medicine’s ctDNA Monitoring Assay, FoundationOne®Tracker, Granted Breakthrough Device Designation by U.S. Food and Drug Administration

Foundation Medicine’s ctDNA Monitoring Assay, FoundationOne ® Tracker, Granted Breakthrough Device Designation by U.S. Food and Drug Administration.

February 15, 2022

·

3 min read

Drug Development

BriOri BioTech Inc. Granted Patent for Topical Formulation of Rofecoxib

BriOri BioTech announces it has received a March 1, 2022, patent issue notification for “Topical Compositions Containing Rofecoxib and Methods of Making and Using the Same.”

February 15, 2022

·

4 min read

Genetown

Repligen Launches AAV Affinity Resins for Gene Therapy PurificationAVIPure® affinity resins address the market need for high performance and caustic stability

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of three advanced affinity chromatography resins for use in gene therapy manufacturing workflows.

February 15, 2022

·

4 min read

Drug Development

TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TG Therapeutics, Inc. today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of multiple sclerosis (RMS).

February 15, 2022

·

8 min read

Pharm Country

Brainstorm Cell Therapeutics Announces Grant of a New Brazilian Patent Covering Methods of Manufacturing NurOwn®

Brainstorm Cell Therapeutics Inc. today announced that the Brazilian Patent Office has granted the patent application.

February 15, 2022

·

5 min read